Log in to save to my catalogue

Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting

Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1984751218

Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting

About this item

Full title

Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting

Publisher

Cham: Springer International Publishing

Journal title

Drugs (New York, N.Y.), 2018-02, Vol.78 (2), p.215-229

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) and CKD is considered a coronary artery disease risk equivalent. So far, statins have been the mainstay of primary and secondary prevention of cardiovascular disease in the general population. However, their benefit on outcomes is limited and controve...

Alternative Titles

Full title

Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1984751218

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1984751218

Other Identifiers

ISSN

0012-6667

E-ISSN

1179-1950

DOI

10.1007/s40265-017-0858-2

How to access this item